PAMA Round Two Is Here: How the CY2027 Clinical Lab Fee Schedule Reset, 15% Annual Cut Caps, and Crosswalk and Gapfill Fights Create Eight New Business Models for Labs, Payers and Investors

CMS just dropped preliminary CY2027 Clinical Lab Fee Schedule rates. Medicare has been overpaying for lab tests by ~16% vs commercial prices. Over 6,400 labs reported. About 77% of priced codes are going down. Here is what that means.

The category breakdown: genomic sequencing down 23%, molecular pathology down 22%, microbiology and immunology each down …